Suurenna

AQUACEL^® Ag+

AQUACEL^® Ag+ on antimikrobinen sidos, jota voidaan käyttää hoidettaessa infektoituneita tai infektioriskin omaavia haavoja. Sidokset on kehitetty hallitsemaan kolmea yleisintä haavanhoidon haastetta – haavaeritettä, infektiota ja biofilmiä. AQUACEL^® Ag+ -sidos koostuu tutkitusta Hydrofiber^®-teknologiasta ja Ag+ -teknologiasta - ainutlaatuinen yhdistelmä hopeaa sekä biofilmiä hajoittavia ainesosia.¹

AQUACEL^® Ag+ -sidos koostuu kahdesta Hydrofiber^®-kerroksesta, jotka on yhdistetty ommelluilla vahvistekuiduilla. Sidokseen lisätty materiaali ja ommellut vahvistekuidut antavat sidokselle 50 % enemmän imukykyä ja 9 kertaa paremman vetolujuuden verrattuna AQUACEL^® Ag -sidokseen.^2*

AQUACEL^® Ag+ -nauhat ovat myös ommelvahvisteisia.

* Osoitettu in-vitro

Tuotenumero	Tuotekuvaus	Koko	kpl/pkt
413566	AQUACEL^® Ag+	5x5cm (2" x 2")	10 kpl
413567	AQUACEL^® Ag+	10x10cm (4" x 4")	10 kpl
413568	AQUACEL^® Ag+	15x15cm (6" x 6")	5 kpl
413569	AQUACEL^® Ag+	20x30cm (8" x 12")	5 kpl
413581	AQUACEL^® Ag+	4x10cm (1½" x 4")	10 kpl
413598	AQUACEL^® Ag+	4x20cm (1½" x 8")	10 kpl
413599	AQUACEL^® Ag+	4x30cm (1½" x 12")	10 kpl
413570	AQUACEL^® Ag+ -nauha	1x45cm (.39" x 18")	5 kpl
413571	AQUACEL^® Ag+ -nauha	2x45cm (.75" x 18")	5 kpl

Tuotenumero: 413566
Tuotekuvaus: AQUACEL^® Ag+
Koko: 5x5cm (2" x 2")
kpl/pkt: 10 kpl

Tuotenumero: 413567
Tuotekuvaus: AQUACEL^® Ag+
Koko: 10x10cm (4" x 4")
kpl/pkt: 10 kpl

Tuotenumero: 413568
Tuotekuvaus: AQUACEL^® Ag+
Koko: 15x15cm (6" x 6")
kpl/pkt: 5 kpl

Tuotenumero: 413569
Tuotekuvaus: AQUACEL^® Ag+
Koko: 20x30cm (8" x 12")
kpl/pkt: 5 kpl

Tuotenumero: 413581
Tuotekuvaus: AQUACEL^® Ag+
Koko: 4x10cm (1½" x 4")
kpl/pkt: 10 kpl

Tuotenumero: 413598
Tuotekuvaus: AQUACEL^® Ag+
Koko: 4x20cm (1½" x 8")
kpl/pkt: 10 kpl

Tuotenumero: 413599
Tuotekuvaus: AQUACEL^® Ag+
Koko: 4x30cm (1½" x 12")
kpl/pkt: 10 kpl

Tuotenumero: 413570
Tuotekuvaus: AQUACEL^® Ag+ -nauha
Koko: 1x45cm (.39" x 18")
kpl/pkt: 5 kpl

Tuotenumero: 413571
Tuotekuvaus: AQUACEL^® Ag+ -nauha
Koko: 2x45cm (.75" x 18")
kpl/pkt: 5 kpl

AQUACEL^® Ag+ -sidos sisältää kaksi tehokasta teknologiaa, jotka yhdessä hallitsevat kolme tavallisinta haavanhoidon haastetta – haavaeritteen, infektion ja biofilmin.

Ag+ -teknologia on ainutlaatuinen biofilmiin tehoava teknologia, joka:^*1

HAJOTTAA biofilmin, jolloin bakteerit tulevat esille^3-5
TUHOAA laaja-alaisesti bakteereja (sisältämällään hopealla), kuten antibioottiresistenttejä superbakteereita^*4-6
EHKÄISEE biofilmin uudelleen muodostumista ^*4,5

Hydrofiber^®-teknologia auttaa luomaan optimaaliset olosuhteet haavan paranemiselle ja Ag+ -teknologian toiminnalle.

LUKITSEE haavaeritteen, bakteerit ja biofilmin sekä vähentää ristikontaminaatiota ja estää maseraatiota^*7-12
MUOTOUTUU TARKASTI haavan pohjaan, ylläpitää optimaalisen kosteustasapainon ja minimoi "tyhjän tilan", joissa bakteerit ja biofilmi voivat kasvaa^*13-15
REAGOI haavan olosuhteisiin muodostamalla koossapysyvän geelin ja auttaa näin vähentämään sidoksen vaihtoon liittyvää kipua^*16-18

AQUACEL^® Ag+ -sidosta voidaan käyttää:

haavoissa, joissa tarvitaan tehokasta suojaa vähentämään infektioriskiä
haavoissa, joissa on infektio tai riski infektiolle
diabeettisissä jalkahaavoissa, säärihaavoissa (laskimo- ja valtimoperäiset sekä eri syistä johtuvat säärihaavat) sekä painehaavoissa (pinnalliset ja syvät)
kirurgisissa haavoissa
traumaperäisissä haavoissa
verta tihkuvissa haavoissa, joita esimerkiksi puhdistettu mekaanisesti tai kirurgisesti
erittävissä onkologisissa haavoissa, kuten esimerkiksi sienimäiset ihokasvaimet, fungoides-karsinooma, ihometastaasi, Kaposin sarkooma ja angiosarkooma
haavoissa, joissa bakteerien epäillään aiheuttavan kroonisuutta/paranemattomuutta

Onkalo- ja fistelihaavoille suosittelemme käytettävän AQUACEL^® Ag+ -nauhasidoksia.

* Osoitettu in-vitro

Referenssit

1. Composition comprising antimicrobial metal ions and a quaternary cationic surfactant. Scientific Background Report. WO 2012136968 A1, 2012, Data on file, ConvaTec Inc.2. Assessment of the in vitro Physical Properties of AQUACEL EXTRA, AQUACEL^® Ag EXTRA™ and AQUACEL^® Ag+ EXTRA™ dressings. Scientific background report. WHRIA3817 TA297, 2013, Data on File, ConvaTec Inc.

3. Physical Disruption of Biofilm by AQUACEL^® Ag+ Wound Dressing. Scientific Background Report. WHRI3850 MA232, 2013, Data on file, ConvaTec Inc.

4. Antimicrobial activity and prevention of biofilm reformation by AQUACEL^® Ag+ EXTRA™ dressing. Scientific Background Report. WHRI3857 MA236, 2013, Data on file, ConvaTec Inc.

5. Antimicrobial activity against CA-MRSA and prevention of biofilm reformation by AQUACEL^® Ag+ EXTRA™ dressing. Scientific Background Report. WHRI3875 MA239, 2013, Data on file, ConvaTec Inc.

6. Bowler PG, Welsby S, Towers V, Booth V, Hogarth A, Rowlands V, Joseph A, et al, 2012. Multidrug-resistant organisms, wounds and topical antimicrobial protection. Int Wound J. 9: 387-396.

7. Newman GR, Walker M, Hobot JA, Bowler PG, 2006. Visualisation of bacterial sequestration and bacterial activity within hydrating Hydrober^® wound dressings. Biomaterials; 27:1129-1139.

8. Walker M, Hobot JA, Newman GR, Bowler PG, 2003. Scanning electron microscopic examination of bacterial immobilization in a carboxymethyl cellulose (AQUACEL^®) and alginate dressing. Biomaterials; 24: 883-890.

9. Bowler PG, Jones SA, Davies BJ, Coyle E, 1999. Infection control properties of some wound dressings. J. Wound Care; 8: 499-502.

10. Walker M, Bowler PG, Cochrane CA, 2007. In vitro studies to show sequestration of matrix metalloproteinases by silver-containing wound care products. Ostomy/Wound Management. 2007; 53: 18-25.

11. Walker M and Parsons D, 2010. Hydrofiber Technology: its role in exudate management. Wounds UK; 6: 31-38.

12. Parsons D, Bowler PG, Myles V, Jones SA, 2005. Silver antimicrobial dressings in wound management: A comparison of antibacterial, physical and chemical characteristics. WOUNDS;17: 222-232.

13. Jones SA, Bowler PG, Walker M, 2005. Antimicrobial activity of silver-containing dressings is influenced by dressing conformability with a wound surface. WOUNDS; 17: 263-270.

14. Bowler P, Jones S, Towers V, Booth R, Parsons D, Walker M, 2010. Dressing conformability and silver-containing wound dressings. Wounds UK; 6: 14-20.

15. Walker M, Jones S, Parsons D, Booth R, Cochrane C, Bowler P, 2011. Evaluation of low-adherent antimicrobial dressings. Wounds UK; 7: 32-45.

16. Barnea Y, Armir A, Leshem D, Zaretski A, Weiss J, Shafir R, et al, 2004. Clinical comparative study of Aquacel and paraffin gauze dressing for split-skin donor site treatment. Ann Plast Surg; 53: 132-136.

17. Kogan L, Moldavsky M, Szvalb S, Govrin-Yehudain J, 2004. Comparative study of Aquacel and Silverol treatment in burns. Ann Burns Fire Disasters; 17: 201-207.

18. Brunner U, Eberlein T, 2000. Experiences with hydrofibres in the moist treatment of chronic wounds, in particular of diabetic foot. VASA; 29: 253-257.

Global ConvaTec site:www.convatec.com

The Americas

Europe

Middle East & Africa

Asia Pacific

Haavanhoito

AQUACEL^® Ag+

Referenssit

3. Physical Disruption of Biofilm by AQUACEL^® Ag+ Wound Dressing. Scientific Background Report. WHRI3850 MA232, 2013, Data on file, ConvaTec Inc.

4. Antimicrobial activity and prevention of biofilm reformation by AQUACEL^® Ag+ EXTRA™ dressing. Scientific Background Report. WHRI3857 MA236, 2013, Data on file, ConvaTec Inc.

5. Antimicrobial activity against CA-MRSA and prevention of biofilm reformation by AQUACEL^® Ag+ EXTRA™ dressing. Scientific Background Report. WHRI3875 MA239, 2013, Data on file, ConvaTec Inc.

6. Bowler PG, Welsby S, Towers V, Booth V, Hogarth A, Rowlands V, Joseph A, et al, 2012. Multidrug-resistant organisms, wounds and topical antimicrobial protection. Int Wound J. 9: 387-396.

7. Newman GR, Walker M, Hobot JA, Bowler PG, 2006. Visualisation of bacterial sequestration and bacterial activity within hydrating Hydrober^® wound dressings. Biomaterials; 27:1129-1139.

8. Walker M, Hobot JA, Newman GR, Bowler PG, 2003. Scanning electron microscopic examination of bacterial immobilization in a carboxymethyl cellulose (AQUACEL^®) and alginate dressing. Biomaterials; 24: 883-890.

9. Bowler PG, Jones SA, Davies BJ, Coyle E, 1999. Infection control properties of some wound dressings. J. Wound Care; 8: 499-502.

10. Walker M, Bowler PG, Cochrane CA, 2007. In vitro studies to show sequestration of matrix metalloproteinases by silver-containing wound care products. Ostomy/Wound Management. 2007; 53: 18-25.

11. Walker M and Parsons D, 2010. Hydrofiber Technology: its role in exudate management. Wounds UK; 6: 31-38.

12. Parsons D, Bowler PG, Myles V, Jones SA, 2005. Silver antimicrobial dressings in wound management: A comparison of antibacterial, physical and chemical characteristics. WOUNDS;17: 222-232.

13. Jones SA, Bowler PG, Walker M, 2005. Antimicrobial activity of silver-containing dressings is influenced by dressing conformability with a wound surface. WOUNDS; 17: 263-270.

14. Bowler P, Jones S, Towers V, Booth R, Parsons D, Walker M, 2010. Dressing conformability and silver-containing wound dressings. Wounds UK; 6: 14-20.

15. Walker M, Jones S, Parsons D, Booth R, Cochrane C, Bowler P, 2011. Evaluation of low-adherent antimicrobial dressings. Wounds UK; 7: 32-45.

16. Barnea Y, Armir A, Leshem D, Zaretski A, Weiss J, Shafir R, et al, 2004. Clinical comparative study of Aquacel and paraffin gauze dressing for split-skin donor site treatment. Ann Plast Surg; 53: 132-136.

17. Kogan L, Moldavsky M, Szvalb S, Govrin-Yehudain J, 2004. Comparative study of Aquacel and Silverol treatment in burns. Ann Burns Fire Disasters; 17: 201-207.

18. Brunner U, Eberlein T, 2000. Experiences with hydrofibres in the moist treatment of chronic wounds, in particular of diabetic foot. VASA; 29: 253-257.

COVID-19

The Americas

Europe

Middle East & Africa

Asia Pacific

AQUACEL® Ag+

Referenssit

3. Physical Disruption of Biofilm by AQUACEL® Ag+ Wound Dressing. Scientific Background Report. WHRI3850 MA232, 2013, Data on file, ConvaTec Inc.

4. Antimicrobial activity and prevention of biofilm reformation by AQUACEL® Ag+ EXTRA™ dressing. Scientific Background Report. WHRI3857 MA236, 2013, Data on file, ConvaTec Inc.

5. Antimicrobial activity against CA-MRSA and prevention of biofilm reformation by AQUACEL® Ag+ EXTRA™ dressing. Scientific Background Report. WHRI3875 MA239, 2013, Data on file, ConvaTec Inc.

6. Bowler PG, Welsby S, Towers V, Booth V, Hogarth A, Rowlands V, Joseph A, et al, 2012. Multidrug-resistant organisms, wounds and topical antimicrobial protection. Int Wound J. 9: 387-396.

7. Newman GR, Walker M, Hobot JA, Bowler PG, 2006. Visualisation of bacterial sequestration and bacterial activity within hydrating Hydrober® wound dressings. Biomaterials; 27:1129-1139.

8. Walker M, Hobot JA, Newman GR, Bowler PG, 2003. Scanning electron microscopic examination of bacterial immobilization in a carboxymethyl cellulose (AQUACEL®) and alginate dressing. Biomaterials; 24: 883-890.

9. Bowler PG, Jones SA, Davies BJ, Coyle E, 1999. Infection control properties of some wound dressings. J. Wound Care; 8: 499-502.

10. Walker M, Bowler PG, Cochrane CA, 2007. In vitro studies to show sequestration of matrix metalloproteinases by silver-containing wound care products. Ostomy/Wound Management. 2007; 53: 18-25.

11. Walker M and Parsons D, 2010. Hydrofiber Technology: its role in exudate management. Wounds UK; 6: 31-38.

12. Parsons D, Bowler PG, Myles V, Jones SA, 2005. Silver antimicrobial dressings in wound management: A comparison of antibacterial, physical and chemical characteristics. WOUNDS;17: 222-232.

13. Jones SA, Bowler PG, Walker M, 2005. Antimicrobial activity of silver-containing dressings is influenced by dressing conformability with a wound surface. WOUNDS; 17: 263-270.

14. Bowler P, Jones S, Towers V, Booth R, Parsons D, Walker M, 2010. Dressing conformability and silver-containing wound dressings. Wounds UK; 6: 14-20.

15. Walker M, Jones S, Parsons D, Booth R, Cochrane C, Bowler P, 2011. Evaluation of low-adherent antimicrobial dressings. Wounds UK; 7: 32-45.

16. Barnea Y, Armir A, Leshem D, Zaretski A, Weiss J, Shafir R, et al, 2004. Clinical comparative study of Aquacel and paraffin gauze dressing for split-skin donor site treatment. Ann Plast Surg; 53: 132-136.

17. Kogan L, Moldavsky M, Szvalb S, Govrin-Yehudain J, 2004. Comparative study of Aquacel and Silverol treatment in burns. Ann Burns Fire Disasters; 17: 201-207.

18. Brunner U, Eberlein T, 2000. Experiences with hydrofibres in the moist treatment of chronic wounds, in particular of diabetic foot. VASA; 29: 253-257.

AQUACEL^® Ag+

3. Physical Disruption of Biofilm by AQUACEL^® Ag+ Wound Dressing. Scientific Background Report. WHRI3850 MA232, 2013, Data on file, ConvaTec Inc.

4. Antimicrobial activity and prevention of biofilm reformation by AQUACEL^® Ag+ EXTRA™ dressing. Scientific Background Report. WHRI3857 MA236, 2013, Data on file, ConvaTec Inc.

5. Antimicrobial activity against CA-MRSA and prevention of biofilm reformation by AQUACEL^® Ag+ EXTRA™ dressing. Scientific Background Report. WHRI3875 MA239, 2013, Data on file, ConvaTec Inc.

7. Newman GR, Walker M, Hobot JA, Bowler PG, 2006. Visualisation of bacterial sequestration and bacterial activity within hydrating Hydrober^® wound dressings. Biomaterials; 27:1129-1139.

8. Walker M, Hobot JA, Newman GR, Bowler PG, 2003. Scanning electron microscopic examination of bacterial immobilization in a carboxymethyl cellulose (AQUACEL^®) and alginate dressing. Biomaterials; 24: 883-890.